|
Showing 1 - 2 of
2 matches in All Departments
Adenosine A2A receptor antagonists have shown great promise in the
treatment of Parkinson's Disease and alleviation of symptoms. This
book addresses various aspects of this class of drugs from their
chemical development to their clinical use. Among the many
insightful chapters contained in this book, there are three unique
reviews that have not previously been published in any format: (1)
a history of istradefylline, the first A2A antagonist approved for
treatment of Parkinson's Disease, (2) an overview of neuroimaging
studies in human death and disease and (3) a study of urate as a
possible biomarker and neuroprotectant.
Adenosine A2A receptor antagonists have shown great promise in the
treatment of Parkinson's Disease and alleviation of symptoms. This
book addresses various aspects of this class of drugs from their
chemical development to their clinical use. Among the many
insightful chapters contained in this book, there are three unique
reviews that have not previously been published in any format: (1)
a history of istradefylline, the first A2A antagonist approved for
treatment of Parkinson's Disease, (2) an overview of neuroimaging
studies in human death and disease and (3) a study of urate as a
possible biomarker and neuroprotectant.
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.